O10.07 RANDOMIZED PHASE II STUDY OF AXITINIB VS. STANDARD OF CARE IN PATIENTS WITH RECURRENT GLIOBLASTOMA

INTRODUCTION: Glioblastoma (GB) associated neo-angiogenesis is mediated by vascular endothelial growth factor receptor (VEGFR) signal transduction. Axitinib is an oral small molecule tyrosine kinase inhibitor with high affinity and specificity for the VEGF-receptors, approved for the treatment of me...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Duerinck, J., Du Four, S., Bouttens, F., Verschaeve, V., Everaert, H., De Raedt, S., Van Binst, A., Neyns, B.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Oral Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185859/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.88
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados